Endiya Partners is an early-stage venture capital fund that invests in Indian product start-ups that are globally relevant. Endiya’s portfolio consists of disruptive and category-defining companies across Technology, Healthcare, Financial Services, and Deeptech sectors. Leveraging deep domain expertise along with vast entrepreneurial and operating experience, the Endiya team plays a key role in co-creating scalable businesses while bridging a funding gap between Angel and Series A investments in the venture capital spectrum of India. Endiya's current portfolio includes AquaExchange, Cell Propulsion, Curefit, Darwinbox, Expertia, Eyestem, Grip Invest, Gigforce, Karkinos Healthcare, Kissht, Myelin Foundry, Mylo, Qapita, Scrut Automation, SigTuple, Slang Labs, Sugarfit, SuperBeings, Synapsica, Upside AI and Zluri. Endiya Team has successfully invested and exited companies like Little Eye Labs (Facebook), StyleCraze (istyle - Japan), ShieldSquare (Radware - Israel), and Steradian Semiconductors (Renesas - Japan).